I think that’s the problem here with the market. The dengue fever is too complex and difficult for the market to fully understand and ISLA 101 is trying to get some definition for itself in what appears to be a complex health problem.
Markets don’t like complexity. Look at how many investors here are confused. Here is a summary so far:- “Are the results good? Does it work well enough? Please help I’m trying to Understand, is it a therapeutic or preventative? What about the dengue vaccine I’ve read about, aren’t there new vaccine trials? And the FDA is anti vaccine at the moment?? And what about the small trial cohort? Do we need to do a larger trial? How much will that cost?”. Etc etc etc
One thing I do know is that markets rightly or wrongly crave CERTAINTY. And that’s not happening here at the moment.
ILA Price at posting:
18.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)